Literature DB >> 8982346

Structure-activity relationships of cephalosporins having a (dimethylisoxazolidinio)vinyl moiety at their 3-position.

R Hara1, K Sakamoto, H Hisamichi, N Nagano.   

Abstract

A series of cephalosporins having a (dimethylisoxazolidinio)vinyl group at their 3-position were synthesized to investigate their structure-activity relationships. With regard to the olefin geometry, the (E)-vinyl compound exhibited higher in vitro activity than the (Z)-compound. Regarding the C-7 substituents, the replacement of 2-aminothiazole with 5-amino-1,2,4-thiadiazole increased the anti-pseudomonal activity. Determination of the absolute configuration of the C-3 substituent is also presented. Among the compounds synthesized, we selected 7 beta-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimi no)acetamido]-3-[(E)-2-((S)-2,2-dimethyl-5-isoxazolidinio)vinyl ]-3-cephem-4-carboxylate (YM-40220), which showed well-balanced in vitro activity and an excellent in vivo efficacy against Staphylococcus aureus Smith, as a candidate for further development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982346     DOI: 10.7164/antibiotics.49.1162

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.

Authors:  Yazala Jyothsna Pragathi; Reddymasu Sreenivasulu; Deekala Veronica; Rudraraju Ramesh Raju
Journal:  Arab J Sci Eng       Date:  2020-05-22       Impact factor: 2.334

2.  A one-pot multistep cyclization yielding thiadiazoloimidazole derivatives.

Authors:  Debabrata Samanta; Anup Rana; Jan W Bats; Michael Schmittel
Journal:  Beilstein J Org Chem       Date:  2014-12-15       Impact factor: 2.883

3.  Synthesis and preliminary antimicrobial activities of new arylideneamino-1,3,4-thiadiazole-(thio/dithio)-acetamido cephalosporanic acids.

Authors:  Shakir Mahmood Alwan
Journal:  Molecules       Date:  2012-01-19       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.